Organization
Nippon Medical School Hospital
4 abstracts
Abstract
New drugs to prevent oxaliplatin-induced peripheral neuropathy: A double-blind, randomized study.Org: Nippon Medical School Hospital, Kansai Rosai Hospital, Fukui-ken Saiseikai Hospital, Hyogo Medical University, Toyama Prefectural Central Hospital,
Abstract
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC (UNICORN): A phase 2 study.Org: National Cancer Center Hospital East, Kashiwa, Japan, Graduate School of Medicine, The University of Tokyo, Nippon Medical School Hospital, Yamaguchi University Graduate School of Medicine, Tokyo Metropolitan Komagome Hospital,
Abstract
First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057).Org: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tohoku University Graduate School of Medicine, Nippon Medical School Hospital, Niigata University Graduate School of Medical and Dental Sciences, Japanese Red Cross Okayama Hospital,
Abstract
Activated platelets are increased in circulation of patients with systemic sclerosis and associated with clinical characteristicsOrg: Keio University School of Medicine, Nippon Medical School Hospital, Graduate School of Medicine, Tokyo, Japan,